North America Protein Chip Market is segmented By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Antibody Characterization), By End-User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceuticals & Biotechnological Companies), and By Country (US, Canada, and Rest of North America) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Report Overview
The North America Protein Chip Market is expected to grow at a CAGR of 18.13% during the forecast period 2023-2030.
Protein microarrays, also known as protein chips, are high-density parallel assay systems containing small amounts of proteins. Protein chips play an important function in diagnostics. With the help of these chips, healthcare providers can check the level of infection for a particular disease or disorder.
Protein chips have been extensively employed in healthcare and biological industries to conduct fundamental research. Furthermore, these chips have been used in drug development research initiatives including contagious and lethal disorders. Protein chips are made comprised of a support surface, such as a glass slide or microtitre plate, that aids in the capture of protein in use, and these molecules are then labelled and assembled in a dye of a certain colour and added to the array. Any interaction between them is then signalled and recorded for future experimentation.
North America Protein Chip Market Scope
|
Metrics |
Details |
|
CAGR |
18.13% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Technology, Application, and End User |
|
Countries Covered |
US, Canada and Rest of North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Drivers
Increasing Prevalence of Cancer & Significant R&D Investments Drive the Market Growth
The protein chip market in North America is expected to expand substantially in the next years as a result of increasing demand for personalized therapy, considerable R&D expenditures, rising cancer incidence rates, and increased usage of enhanced diagnostic testing equipment.
Furthermore, technological advancements in diagnostic testing and the increased prevalence of cancer are projected to fuel the global protein chip market. Moreover, the rising awareness of customized treatment is projected to benefit the North American protein chip industry.
Segment Analysis
The North America Protein Chip Market is segmented based on technology, application, and end user.
By Technology: The Functional Protein Microarrays Segment is Anticipated to have the Largest Market Share
Notably, the functional protein microarray segment is expected to have the largest share of the market during the projection period, owing to its widespread use in sophisticated diagnostics. High-throughput investigation of protein interactions, protein-protein binding, enzyme activity, and post-translational changes is possible using functional protein microarrays. This thorough knowledge helps with drug development, biomarker identification, and comprehension of complicated biological circuits. The relevance of the sector in customized medicine and diagnostics, where it permits the evaluation of unique reactions to treatments, contributes to its popularity.
Market Key Players
Significant players in the North America Protein Chip Market include SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
